The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery

Standard

The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery. / Gonzalez Melo, Mary; Remacle, Noémie; Cudré-Cung, Hong-Phuc; Roux, Clothilde; Poms, Martin; Cudalbu, Cristina; Barroso, Madalena; Gersting, Søren Waldemar; Feichtinger, René Günther; Mayr, Johannes Adalbert; Costanzo, Michele; Caterino, Marianna; Ruoppolo, Margherita; Rüfenacht, Véronique; Häberle, Johannes; Braissant, Olivier; Ballhausen, Diana.

In: MOL GENET METAB, Vol. 133, No. 2, 06.2021, p. 157-181.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Gonzalez Melo, M, Remacle, N, Cudré-Cung, H-P, Roux, C, Poms, M, Cudalbu, C, Barroso, M, Gersting, SW, Feichtinger, RG, Mayr, JA, Costanzo, M, Caterino, M, Ruoppolo, M, Rüfenacht, V, Häberle, J, Braissant, O & Ballhausen, D 2021, 'The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery', MOL GENET METAB, vol. 133, no. 2, pp. 157-181. https://doi.org/10.1016/j.ymgme.2021.03.017

APA

Gonzalez Melo, M., Remacle, N., Cudré-Cung, H-P., Roux, C., Poms, M., Cudalbu, C., Barroso, M., Gersting, S. W., Feichtinger, R. G., Mayr, J. A., Costanzo, M., Caterino, M., Ruoppolo, M., Rüfenacht, V., Häberle, J., Braissant, O., & Ballhausen, D. (2021). The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery. MOL GENET METAB, 133(2), 157-181. https://doi.org/10.1016/j.ymgme.2021.03.017

Vancouver

Bibtex

@article{65722b8a41724f72a815a229e65bc876,
title = "The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery",
abstract = "Glutaric aciduria type I (GA-I, OMIM # 231670) is an inborn error of metabolism caused by a deficiency of glutaryl-CoA dehydrogenase (GCDH). Patients develop acute encephalopathic crises (AEC) with striatal injury most often triggered by catabolic stress. The pathophysiology of GA-I, particularly in brain, is still not fully understood. We generated the first knock-in rat model for GA-I by introduction of the mutation p.R411W, the rat sequence homologue of the most common Caucasian mutation p.R402W, into the Gcdh gene of Sprague Dawley rats by CRISPR/Cas9 technology. Homozygous Gcdhki/ki rats revealed a high excretor phenotype, but did not present any signs of AEC under normal diet (ND). Exposure to a high lysine diet (HLD, 4.7%) after weaning resulted in clinical and biochemical signs of AEC. A significant increase of plasmatic ammonium concentrations was found in Gcdhki/ki rats under HLD, accompanied by a decrease of urea concentrations and a concomitant increase of arginine excretion. This might indicate an inhibition of the urea cycle. Gcdhki/ki rats exposed to HLD showed highly diminished food intake resulting in severely decreased weight gain and moderate reduction of body mass index (BMI). This constellation suggests a loss of appetite. Under HLD, pipecolic acid increased significantly in cerebral and extra-cerebral liquids and tissues of Gcdhki/ki rats, but not in WT rats. It seems that Gcdhki/ki rats under HLD activate the pipecolate pathway for lysine degradation. Gcdhki/ki rat brains revealed depletion of free carnitine, microglial activation, astroglyosis, astrocytic death by apoptosis, increased vacuole numbers, impaired OXPHOS activities and neuronal damage. Under HLD, Gcdhki/ki rats showed imbalance of intra- and extracellular creatine concentrations and indirect signs of an intracerebral ammonium accumulation. We successfully created the first rat model for GA-I. Characterization of this Gcdhki/ki strain confirmed that it is a suitable model not only for the study of pathophysiological processes, but also for the development of new therapeutic interventions. We further brought up interesting new insights into the pathophysiology of GA-I in brain and periphery.",
author = "{Gonzalez Melo}, Mary and No{\'e}mie Remacle and Hong-Phuc Cudr{\'e}-Cung and Clothilde Roux and Martin Poms and Cristina Cudalbu and Madalena Barroso and Gersting, {S{\o}ren Waldemar} and Feichtinger, {Ren{\'e} G{\"u}nther} and Mayr, {Johannes Adalbert} and Michele Costanzo and Marianna Caterino and Margherita Ruoppolo and V{\'e}ronique R{\"u}fenacht and Johannes H{\"a}berle and Olivier Braissant and Diana Ballhausen",
note = "Copyright {\textcopyright} 2021 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2021",
month = jun,
doi = "10.1016/j.ymgme.2021.03.017",
language = "English",
volume = "133",
pages = "157--181",
journal = "MOL GENET METAB",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery

AU - Gonzalez Melo, Mary

AU - Remacle, Noémie

AU - Cudré-Cung, Hong-Phuc

AU - Roux, Clothilde

AU - Poms, Martin

AU - Cudalbu, Cristina

AU - Barroso, Madalena

AU - Gersting, Søren Waldemar

AU - Feichtinger, René Günther

AU - Mayr, Johannes Adalbert

AU - Costanzo, Michele

AU - Caterino, Marianna

AU - Ruoppolo, Margherita

AU - Rüfenacht, Véronique

AU - Häberle, Johannes

AU - Braissant, Olivier

AU - Ballhausen, Diana

N1 - Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2021/6

Y1 - 2021/6

N2 - Glutaric aciduria type I (GA-I, OMIM # 231670) is an inborn error of metabolism caused by a deficiency of glutaryl-CoA dehydrogenase (GCDH). Patients develop acute encephalopathic crises (AEC) with striatal injury most often triggered by catabolic stress. The pathophysiology of GA-I, particularly in brain, is still not fully understood. We generated the first knock-in rat model for GA-I by introduction of the mutation p.R411W, the rat sequence homologue of the most common Caucasian mutation p.R402W, into the Gcdh gene of Sprague Dawley rats by CRISPR/Cas9 technology. Homozygous Gcdhki/ki rats revealed a high excretor phenotype, but did not present any signs of AEC under normal diet (ND). Exposure to a high lysine diet (HLD, 4.7%) after weaning resulted in clinical and biochemical signs of AEC. A significant increase of plasmatic ammonium concentrations was found in Gcdhki/ki rats under HLD, accompanied by a decrease of urea concentrations and a concomitant increase of arginine excretion. This might indicate an inhibition of the urea cycle. Gcdhki/ki rats exposed to HLD showed highly diminished food intake resulting in severely decreased weight gain and moderate reduction of body mass index (BMI). This constellation suggests a loss of appetite. Under HLD, pipecolic acid increased significantly in cerebral and extra-cerebral liquids and tissues of Gcdhki/ki rats, but not in WT rats. It seems that Gcdhki/ki rats under HLD activate the pipecolate pathway for lysine degradation. Gcdhki/ki rat brains revealed depletion of free carnitine, microglial activation, astroglyosis, astrocytic death by apoptosis, increased vacuole numbers, impaired OXPHOS activities and neuronal damage. Under HLD, Gcdhki/ki rats showed imbalance of intra- and extracellular creatine concentrations and indirect signs of an intracerebral ammonium accumulation. We successfully created the first rat model for GA-I. Characterization of this Gcdhki/ki strain confirmed that it is a suitable model not only for the study of pathophysiological processes, but also for the development of new therapeutic interventions. We further brought up interesting new insights into the pathophysiology of GA-I in brain and periphery.

AB - Glutaric aciduria type I (GA-I, OMIM # 231670) is an inborn error of metabolism caused by a deficiency of glutaryl-CoA dehydrogenase (GCDH). Patients develop acute encephalopathic crises (AEC) with striatal injury most often triggered by catabolic stress. The pathophysiology of GA-I, particularly in brain, is still not fully understood. We generated the first knock-in rat model for GA-I by introduction of the mutation p.R411W, the rat sequence homologue of the most common Caucasian mutation p.R402W, into the Gcdh gene of Sprague Dawley rats by CRISPR/Cas9 technology. Homozygous Gcdhki/ki rats revealed a high excretor phenotype, but did not present any signs of AEC under normal diet (ND). Exposure to a high lysine diet (HLD, 4.7%) after weaning resulted in clinical and biochemical signs of AEC. A significant increase of plasmatic ammonium concentrations was found in Gcdhki/ki rats under HLD, accompanied by a decrease of urea concentrations and a concomitant increase of arginine excretion. This might indicate an inhibition of the urea cycle. Gcdhki/ki rats exposed to HLD showed highly diminished food intake resulting in severely decreased weight gain and moderate reduction of body mass index (BMI). This constellation suggests a loss of appetite. Under HLD, pipecolic acid increased significantly in cerebral and extra-cerebral liquids and tissues of Gcdhki/ki rats, but not in WT rats. It seems that Gcdhki/ki rats under HLD activate the pipecolate pathway for lysine degradation. Gcdhki/ki rat brains revealed depletion of free carnitine, microglial activation, astroglyosis, astrocytic death by apoptosis, increased vacuole numbers, impaired OXPHOS activities and neuronal damage. Under HLD, Gcdhki/ki rats showed imbalance of intra- and extracellular creatine concentrations and indirect signs of an intracerebral ammonium accumulation. We successfully created the first rat model for GA-I. Characterization of this Gcdhki/ki strain confirmed that it is a suitable model not only for the study of pathophysiological processes, but also for the development of new therapeutic interventions. We further brought up interesting new insights into the pathophysiology of GA-I in brain and periphery.

U2 - 10.1016/j.ymgme.2021.03.017

DO - 10.1016/j.ymgme.2021.03.017

M3 - SCORING: Journal article

C2 - 33965309

VL - 133

SP - 157

EP - 181

JO - MOL GENET METAB

JF - MOL GENET METAB

SN - 1096-7192

IS - 2

ER -